Arcus Biosciences, Inc.

RCUS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017
Assets
Cash & Equivalents $98.4M
Accounts Receivable —
Inventory —
Total Current Assets $176.9M
Property, Plant & Equipment $11.2M
Goodwill —
Intangible Assets (Excl. Goodwill) —
Total Assets $190.5M
Liabilities
Accounts Payable $3.8M
Total Current Liabilities $12.7M
Long-Term Debt —
Total Liabilities $36.6M
Stockholders' Equity
Retained Earnings $-73.2M
Total Stockholders' Equity $-72.3M
← Newer Page 2 of 2 Older →